The importance of the system of obligatory medical insurance in improving the availability and quality of cancer care in the Chelyabinsk region

Reducing mortality from major chronic non-communicable diseases is a priority direction for the development of the healthcare system. At the state level, the task has been set to combat oncological diseases as one of the main causes of mortality of the population. Rational and sufficient financial provision of oncological care at the expense of mandatory medical insurance largely determines the use of modern medicines, effective treatment regimens and compliance with the established deadlines for providing medical care to patients.
The purpose of the work is to this study analyzes the volume and quality of cancer care and its financing in the Chelyabinsk region on the basis of information from the regional foundation of obligatory medical insurance.
Materials and methods: personalized accounting of insured persons, analytical reports, tables, databases, financial and methodological documents in the field of obligatory medical insurance. In the course of the research, the following scientific methods were used: system analysis, comparing, generalization.
The results of the study show that the modernization of the approach to financial provision of oncological care in the Chelyabinsk region has increased its availability and quality for the population. The development of medical science in the field of oncology follows the path of targeting therapy, which makes it possible to successfully treat patients for whom standard treatment methods are ineffective, and allows finding ways to correct the identified pathology.
Сonclusion: the development of the pharmaceutical market leads to the emergence of new, often expensive, medicines. In this regard, we can only expect a further increase in the need for chemotherapeutic drugs and, as a result, an increase in costs. In this regard, the improvement of the drug supply system, including obligatory medical insurance, is one of the priority areas in ensuring the availability and quality of medical care.

1. Kadyrov F.N., Obuhova V.N., Bazarova I.N. Health care financing in 2020: priorities within the national project “health care”. Нealth care manager. 2020; 1: 62–72 (In Russian).

2. Vazhenin A.V., Novikova S.V., Tyukov Yu.A. Experience and opportunities of publicprivate partnership in oncology (based on scientific publications). South Ural medical journal. 2020; 2: 59–69 (In Russian).

3. Tishkina S.N., Matskevich V.E., Ledovskikh Yu.A., et al. Regulatory framework of the oncological medical care provision. FARMAKOECONOMICA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2020; 13(3): 304–315 (In Russian). https://doi.org/10.17749/2070-4909/farmakoekonomika.2020.052

4. Zudin A.B., Linnik S.A., Shepin V.O., et al. Analysis of the lists of drugs for the treatment of patients with malignant neoplasms for the possibility of using these drugs on an outpatient basis. Problems in oncology. 2020; 66(6): 609–617 (In Russian). https://doi.org/10.37469/0507-3758-2020-66-6-609-617

5. Lazareva M.L., Zheleznyakova I.A., Avxentyeva M.V., et al. Main changes in the model of diagnosis-related groups in Russia in 2020. Medical technologies. Assessment and choice. 2020; 1(39): 19–29 (In Russian). https://doi.org/10.31556/2219-0678.2020.39.1.019-029

6. Organization and payment of medical care for patients with malignant neoplasms. By eds. Omelyanovsky V.V., Zheleznyakova I.A., Avxentyeva M.V. Moscow: Hauka, 2021. 208 p (in Russian). ISBN 978-5-02-040889-0

7. Practical Problems in Organization and Payment for Medical Care for Patients with Oncological Diseases Within the Frame of Providing Quality and Safety of Medical Care: Expert Opinion. Medical technologies. Assessment and choice. 2020; 1(39): 43–47 (In Russian). https://doi.org/10.31556/2219-0678.2020.39.1.043-47